Rating15 Sept 2026, 08:00 pm
Mankind Pharma gets 'Leader' ESG rating of 68.21
AI Summary
Mankind Pharma Ltd has received an ESG rating of 68.21 from Niche99 ESG Ratings, placing it in the 'Leader' category. This rating is based on publicly available data for FY 2025-26. Notably, the company did not engage Niche99 for this rating, indicating an independent assessment by the ESG provider. The disclosure is also available on the company's website.
Key Highlights
- Mankind Pharma assigned ESG rating of 68.21.
- Rating places the company in the 'Leader' category.
- Assessment based on FY 2025-26 public data.
- Company did not engage the rating provider.
- Disclosure available on company website.
Price Impact
More from MANKIND